ClinicalTrials.Veeva

Menu

Effects of Roaccutane on Ca, P, PTH and Vitamin D Metabolites in the Treatment of Sever Acne

S

Shahid Beheshti University of Medical Sciences

Status and phase

Completed
Phase 1

Conditions

Acne

Treatments

Drug: isotretinoin (Roaccutane)

Study type

Interventional

Funder types

Other

Identifiers

NCT00416585
src-hmnm-1385

Details and patient eligibility

About

serum levels Ca, P, PTH and vitamin D metabolites before and after treatment with isotretinoin for sever acne

Full description

few studies has been done of serum levels Ca, P, PTH and vitamin D metabolites in patients receiving isotretinoin .In this study we measured serum levels Ca, P, PTH and vitamin D metabolites before and after treatment with isotretinoin for sever acne in 30 patients . the patients had no kown skeletal, endocrine ,renal and gastrointestinal disorders.

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • sever acne

Exclusion criteria

  • renal disorders
  • gastrointestinal disorders
  • skeletal disorders
  • endocrine disorders
  • drugs such as glucocorticoids , thiazide diuretics, mineral multivitamins, anti acids, tetracyclines

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems